You are here: Industry Insights > HPAPI

News List

Research finds 25 percent of drugs contain highly potent compounds europeanpharmaceuticalreview
September 27, 2020
A new report has said that a quarter of drugs globally are based on highly potent active pharmaceutical ingredients.
$65 million expansion to HPAPI manufacturing facility europeanpharmaceuticalreview
September 24, 2020
The expansion will be specifically designed to manufacture high-potency active pharmaceutical ingredients (HPAPIs) and complex antibody-drug conjugates (ADCs).
HPAPI facility developed to produce biodegradable contraceptive molecule europeanpharmaceuticalreview
September 22, 2020
A new HPAPI manufacturing unit has been opened in France, with the capability to make a contraceptive with a superior safety profile and high level of biodegradability.
MilliporeSigma Expands HPAPI and ADC Mfg. Capabilities contractpharma
September 18, 2020
$65 million investment to expand facility near Madison, WI will allow large-scale manufacturing of increasingly potent compounds.
Heraeus expands its platinum-based HPAPI capacity cphi-online
November 26, 2019
Heraeus Pharmaceutical Ingredients, a business line of Heraeus Precious Metals, has expanded its capacity for platinum-based highly potent active pharmaceutical ingredients (HPAPIs) ...
The Latest Innovations in HPAPI Manufacturing Technologies americanpharmaceuticalreview
July 10, 2019
SMi’s inaugural Highly Potent Active Pharmaceutical Ingredients USA Conference, will focus on the latest innovative manufacturing technologies with a special spotlight presentation on effective and safe containment solutions for biologics based HPAPIs, al
Piramal Invests $10 million in Riverview Expansion contractpharma
June 24, 2019
Expands High Potency API Capability to serve the growing ADC market.
Lonza to Expand HPAPI Development and Manufacturing Capacity contractpharma
June 18, 2019
Will develop new facilities at Visp site; enters long term mfg. agreement with AstraZeneca.
Highly Potent Active Pharmaceutical Ingredients USA (HPAPI) Conference worldpharmanews
May 21, 2019
Highly Potent Active Pharmaceutical Ingredients USA (HPAPI) Conference.
Cambrex Completes Highly Potent API Mfg. Site contractpharma
April 15, 2019
Investment in Charles City, IA site totaled $24 million.

Previous page 1 2 3 Next page